Learning Path: Antibody Modeling
Antibodies are a major class of biologics with broad therapeutic applications. Computational modeling plays an important role in different stages of antibody discovery and optimization, spanning from initial structure modeling and refinement to final developability assessment. This learning path provides an overview of Schrödinger tools and workflows for modeling antibodies, with a focus on choosing appropriate approaches based on available information and research goals.
Sequence Analysis
The first step is gathering the available relevant sequence data. Once you have the sequence data, you can perform sequence-based analysis that helps annotate antibody sequences by identifying frameworks, CDR regions, and germline origins. It also helps to flag sequence features that may warrant closer inspection in downstream modeling.
Do you have a structure of the antibody-antigen complex of interest?
If you already have a structure of an antibody-antigen complex, you will need to prepare and refine the structure for downstream tasks.
For which part of the system do you want to predict a structure?
There are two approaches to predict structures – homology modeling and machine learning-based (ML) structure prediction. Homology modeling uses closely related proteins to map structure motifs to a sequence, which is only possible if structures of homologs with sufficiently high sequence identity are available. ML structure prediction uses the similarity to known structures as well, but in a much more holistic fashion. It can be useful to use both approaches and compare the results. Note that the following steps are not exclusive -- you may need to predict structures for both proteins separately, refine them, and then bring them together to obtain the complex structure.
Antibody Structure Prediction
You can predict antibody structures by classical template-based homology modeling or by machine learning approach using the Antibody Structure Prediction panel.
To learn more about the available methods, you can read more in following publications:
Antigen Structure Prediction
You can predict antigen structures by classical template-based homology modeling or by machine learning approach.
Antibody-Antigen Complex Structure Prediction
Structure Quality Assessment and Refinement
Assessing the structure quality of the predicted structure is an important prerequisite before proceeding to subsequent computational analysis, such as antibody-antigen docking.
While structure quality assessment follows common principles for all proteins, refinement strategies often differ for antibodies and antigens due to their distinct structural features. Antibodies have conserved frameworks with highly variable CDR loops (especially CDR-H3), which often require targeted loop refinement. Antigens can range from small, rigid domains to large, flexible or multi-domain proteins, and their refinement typically focuses on overall fold quality and local geometry.
Antibody Engineering
Antibody engineering covers computational and experimental strategies used to design, modify, and optimize antibodies for improved therapeutic performance. This includes improving antigen binding, ensuring structural stability, minimizing developability risks, and tailoring antibody formats and functions for development. Following is a list of some generic resources that introduce you to the protein design tools to introduce mutations and predict their impact on the affinity of the complex:
Additionally, if your antibody structure is derived from a non-human source, you can perform antibody humanization via CDR grafting or residue scanning.
Optimizing Stability and Affinity
MM-GBSA
FRS
FEP+ Residue Scanning (FRS) is an efficient method to triage promising mutants from MM-GBSA residue scanning before performing full protein FEP+ calculations.
Protein FEP+
Humanization
Other
Developability Assessment
Identifying and designing out liabilities before moving to the experimental stage can significantly reduce costs and speed up project timelines.
Conclusion and Next Steps
This concludes the overview of Schrödinger tools and workflows which have been validated for use on or with antibodies and antibody-antigen complexes. For more in-depth guidance on particular scientific workflows, consult our other learning resources.